Abstract
The object of our studies was to investigate the additional use of cytostatic agents in primary therapy of patients with carcinoma of the uterine cervix. During the period of 1961 to 1966 a total of 146 women were treated with such agents, mostly Trenimon, in addition to the conventional basic regimen. The influence of this procedure upon the 5-year-cure-rate could be investigated.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1976 Plenum Press, New York
About this chapter
Cite this chapter
Kaether, M., Franz, G. (1976). Additional Therapy with Trenimon in Treatment of Carcinoma of the Uterine Cervix. In: Hellmann, K., Connors, T.A. (eds) Chemotherapy. Chemotherapy, vol 8. Springer, Boston, MA. https://doi.org/10.1007/978-1-4613-4352-3_53
Download citation
DOI: https://doi.org/10.1007/978-1-4613-4352-3_53
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4613-4354-7
Online ISBN: 978-1-4613-4352-3
eBook Packages: Springer Book Archive